Sign inGet started

Chan Andrew C.

Insider CIK 2131504 · CRVS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CRVS Corvus Pharmaceuticals, In A Award deriv2026-04-232026-04-2730,000— $030,000SEC↗